Cart
sales@molnova.com
1-alpha-H,5-alpha H-guaia-6-ene-4beta,10beta-diol
CAS No. 2013537-81-8
1-alpha-H,5-alpha H-guaia-6-ene-4beta,10beta-diol( —— )
Catalog No. M32246 CAS No. 2013537-81-8
1αH,5αH-guaia-6-ene-4β,10β-diol is a natural product.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 180 | In Stock |
|
| 10MG | 297 | In Stock |
|
| 25MG | 502 | In Stock |
|
| 50MG | 699 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-alpha-H,5-alpha H-guaia-6-ene-4beta,10beta-diol
-
NoteResearch use only, not for human use.
-
Brief Description1αH,5αH-guaia-6-ene-4β,10β-diol is a natural product.
-
Description1αH,5αH-guaia-6-ene-4β,10β-diol is a natural product.
-
In Vitro1αH,5αH-Guaia-6-ene-4β,10β-diol has anti-cancer activities. 1αH,5αH-Guaia-6-ene-4β,10β-diol is against H460, MCF-7, and PC-7 with IC50s of 56.7 μM, 76.7 μM, and 59.0 μM, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2013537-81-8
-
Formula Weight238.37
-
Molecular FormulaC15H26O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2-Hydroxystearic aci...
2-Hydroxystearic acid is a hydroxy fatty acid found in humans and U. armoricana. It reduces the growth of Ehrlich ascites tumor (EAT) cells in vitro when used at a concentration of 100 μM.
-
Demethoxydeacetoxyps...
Demethoxydeacetoxypseudolaric acid B analog has potent activities against HMEC-1, HL-60, A-549, MB-MDA-468, BEL-7402, HCT116, and Hela cells with IC50s ranging from 0.136 to 1.162 μM. and is semi-synthesized by efficient routines from Pseudolaric acid B.
-
Lysionotin
Lysionotin has expectorant, eliminating phlegm, softening effects.
